|Data suggest that CGRP inhibitors are going to usher in a new era in treatment in migraine.
How will these novel agents affect your practice?
AHS attendees and virtual attendees around the world are invited to join us
Therapeutic Advances and Evolving Treatment Strategies:
Approved for AMA PRA Category 1 Credit™
TWO WAYS TO ATTEND
This symposium is a satellite session and not part of the official 59th Annual Scientific Meeting.